The search for biomarkers that quantify biological aging (particularly 'omic'-based
biomarkers) has intensified in recent years. Such biomarkers could predict aging-related …

Advances in proteomic assay technologies has significantly increased coverage and
throughput, enabling recent increases in the number of large-scale population-based …

Objective We aimed to describe plasma protein biomarkers of multiple sclerosis risk and to
explore protein biomarkers of disease severity using radiological outcome measures …

BACKGROUND: Cardiovascular disease (CVD) is among the leading causes of death
worldwide. The discovery of new omics biomarkers could help to improve risk stratification …

Background Beyond mere prognostication, optimal biomarkers of aging provide insights into
qualitative and quantitative features of biological aging and might therefore offer useful …

Background Plasma growth differentiation factor 15 (GDF15) and N-terminal pro-B-type
natriuretic peptide (NT-proBNP) are cardiovascular biomarkers that associate with a range …

Discovery of serum protein biomarkers for Multiple Sclerosis risk and severity could shed
light on pathophysiological mechanisms, suggest new drug targets, enhance the speed of …

Multiomics analyses have identified multiple potential biomarkers of the incidence and
prevalence of complex diseases. However, it is not known which type of biomarker is optimal …